Free Trial
→ 3..2..1.. AI 2.0 ignition (don’t sleep on this) (From Timothy Sykes) (Ad) Free NLTX Stock Alerts

Neoleukin Therapeutics (NLTX) Insider Trading & Ownership

Neoleukin Therapeutics logo
$21.43 -0.53 (-2.41%)
As of 07/11/2025
Compare

Neoleukin Therapeutics (NASDAQ:NLTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.58%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$1.31M
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$5.04K
Get NLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neoleukin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NLTX Insider Buying and Selling by Quarter

Neoleukin Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2023Bros. Advisors Lp BakerDirectorBuy8,347$13.80$115,188.60  
8/15/2023Bros. Advisors Lp BakerDirectorBuy94,440$12.60$1,189,944.00  
8/11/2023Sean Michael SmithCFOSell66$12.40$818.40  
4/3/2023Priti PatelInsiderSell188$13.80$2,594.40  
8/10/2022Sean Michael SmithInsiderSell82$19.80$1,623.60  
(Data available from 1/1/2013 forward)

NLTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Neoleukin Therapeutics includes Bros. Advisors Lp Baker, Priti Patel, and Sean Michael Smith. Learn more on insiders at NLTX.

1.58% of Neoleukin Therapeutics stock is owned by insiders. Learn more on NLTX's insider holdings.

The following insider purchased NLTX shares in the last 24 months: Bros. Advisors Lp Baker ($1,305,132.60).

Insiders have purchased a total of 102,787 NLTX shares in the last 24 months for a total of $1,305,132.60 bought.

The following insider sold NLTX shares in the last 24 months: Sean Michael Smith ($818.40).

Insiders have sold a total of 66 Neoleukin Therapeutics shares in the last 24 months for a total of $818.40 sold.

Neoleukin Therapeutics Key Executives

  • Ms. Donna M. Cochener-Metcalfe J.D. (Age 48)
    General Counsel, Interim CEO & Corporate Secretary
    Compensation: $403.75k
  • Dr. David Baker M.D.
    Ph.D., Co-Founder
  • Mr. Sean Michael Smith (Age 37)
    Interim Chief Financial Officer

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:NLTX) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Hedge fund legend humiliates Bitcoin traders
Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...
Brownstone Research | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
An extra $1,000 per month?
A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...
TradeSmith | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored
Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...
Porter & Company | Sponsored